MG
SNTI icon

MSOP GP’s Senti Biosciences Holdings SNTI Stock Holding History

MSOP GP’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$37.2K Buy
+35,737
New +$63.2K 0.01% 3

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MSOP GP's SNTI Position: Q4 2025 in Review

MSOP GP opened a new position in Senti Biosciences Holdings (SNTI) in Q4 2025: 35,737 shares worth $37.2K. The stake represents 0.01% of the portfolio and ranks #3 among its holdings.

15 funds tracked by Wall St. Rank hold SNTI as of Q4 2025.

  • MSOP GP held 35,737 shares of Senti Biosciences Holdings worth $37.2K as of Q4 2025.
  • Senti Biosciences Holdings was a new MSOP GP position in Q4 2025.
  • Senti Biosciences Holdings made up 0.01% of MSOP GP's portfolio in Q4 2025, its #3 holding.
  • 15 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2025.

Based on MSOP GP's 13F filing for Q4 2025, filed 17 Feb 2026.